Struggling to find Fluticasone/Salmeterol (Advair) at your pharmacy? Learn why this inhaler is hard to find in 2026 and what you can do about it.
You rely on your Fluticasone/Salmeterol inhaler to breathe easier every day. So when your pharmacy tells you they're out of stock — again — it's more than frustrating. It can feel scary.
Whether you know this medication as Advair Diskus, Wixela Inhub, or AirDuo RespiClick, patients across the country have reported difficulty finding it in 2026. In this post, we'll explain what's going on, why it's happening, and — most importantly — what you can do to get your medication.
Fluticasone/Salmeterol is a combination inhaler used to treat asthma and chronic obstructive pulmonary disease (COPD). It contains two active ingredients:
Together, they help prevent asthma attacks and COPD flare-ups. It's taken twice a day and is not a rescue inhaler — it's meant for ongoing, daily maintenance. With over 10 million prescriptions written annually, it's one of the most widely used inhalers in the United States.
For a deeper dive into how this medication works in your body, check out our guide on how Fluticasone/Salmeterol works.
There's no single reason this inhaler is hard to find. Instead, several factors are working together to create supply problems.
Inhalers are some of the most complex medications to manufacture. Unlike a simple pill, a dry powder inhaler like Advair Diskus or Wixela Inhub requires specialized manufacturing equipment, precise metering systems, and strict quality controls. Even small disruptions at a manufacturing facility can slow down production for weeks or months.
Even though generics have been available since 2019 (when the FDA approved Wixela Inhub as the first generic Advair Diskus), only a handful of companies make Fluticasone/Salmeterol inhalers. The main players are GlaxoSmithKline (GSK) for brand-name Advair, Viatris (formerly Mylan) for Wixela Inhub, and Teva for AirDuo RespiClick. When any one manufacturer has a production issue, the entire supply tightens.
The inhaler market has faced broader supply chain challenges, including issues with propellant availability for metered-dose inhalers and raw material sourcing for dry powder devices. These upstream problems ripple down to pharmacy shelves.
Asthma and COPD remain extremely common in the U.S. The American Lung Association estimates that over 25 million Americans have asthma, and more than 16 million have been diagnosed with COPD. As the population ages and diagnoses increase, demand for combination inhalers like Fluticasone/Salmeterol continues to rise — sometimes outpacing supply.
For the latest shortage details, read our Fluticasone/Salmeterol shortage update for 2026.
Running out of your maintenance inhaler isn't something you can just wait out. Here are practical steps you can take right now.
Medfinder can help you check which pharmacies near you have Fluticasone/Salmeterol in stock — in real time. Instead of calling pharmacy after pharmacy, you get answers fast.
If the Advair Diskus 250/50 is out of stock, your pharmacy might have the Wixela Inhub (generic equivalent) or the AirDuo RespiClick (a different dry powder device with the same active ingredients at slightly different doses). Ask your pharmacist or doctor whether switching formulations makes sense for you.
Large chain pharmacies often run out faster because they serve more patients. Smaller, independent pharmacies may have stock that chains don't. Check our guide on how to find Fluticasone/Salmeterol in stock near you for more tips.
If you truly can't find Fluticasone/Salmeterol anywhere, your doctor may be able to switch you to a similar ICS/LABA combination inhaler such as Symbicort (Budesonide/Formoterol), Breo Ellipta (Fluticasone/Vilanterol), or Dulera (Mometasone/Formoterol). Learn more in our post on alternatives to Fluticasone/Salmeterol.
This is critical: never stop taking your maintenance inhaler without talking to your doctor first. Stopping suddenly can lead to worsening asthma or COPD symptoms, including potentially dangerous flare-ups. If you're running low, call your doctor's office — they may be able to provide samples or adjust your treatment plan while you find a supply.
If cost is adding to the stress, know that generic Fluticasone/Salmeterol (Wixela Inhub) can cost as little as $64 with a GoodRx coupon, compared to $250–$500+ for brand-name Advair. GSK and Viatris both offer savings programs that can bring your copay down to as low as $10 per month if you have commercial insurance. Read our full breakdown of how to save money on Fluticasone/Salmeterol.
Fluticasone/Salmeterol being hard to find is stressful, but there are real steps you can take. Use tools like Medfinder to check availability, ask about generics and alternative formulations, and keep your doctor in the loop. Your breathing matters — don't wait until your inhaler is completely empty to start looking.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
